Position | Company | Period |
---|
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-01-25 | 2024-01-23 |
Edgewise Therapeutics Inc
(EWTX)
|
B Purchase |
454,545
+3.3%
11.004,999,995 USD |
454,545 +3.3% | 11.00 | 4,999,995 USD | |
2023-12-29 | 2023-12-28 |
Alpine Immune Sciences Inc
(ALPN)
|
S Sale |
139,166
-34.5%
18.322,549,521 USD |
139,166 -34.5% | 18.32 | 2,549,521 USD | |
2023-12-29 | 2023-12-28 |
Alpine Immune Sciences Inc
(ALPN)
|
S Sale |
1,195,683
-34.5%
18.3221,904,913 USD |
1,195,683 -34.5% | 18.32 | 21,904,913 USD | |
2023-12-29 | 2023-12-28 |
Alpine Immune Sciences Inc
(ALPN)
|
S Sale |
3,128
-0.8%
19.8261,997 USD |
3,128 -0.8% | 19.82 | 61,997 USD | |
2023-12-29 | 2023-12-28 |
Alpine Immune Sciences Inc
(ALPN)
|
S Sale |
26,872
-0.8%
19.82532,603 USD |
26,872 -0.8% | 19.82 | 532,603 USD | |
2023-12-29 | 2023-12-27 |
Alpine Immune Sciences Inc
(ALPN)
|
S Sale |
18,922
-4.4%
19.96377,683 USD |
18,922 -4.4% | 19.96 | 377,683 USD | |
2023-12-29 | 2023-12-27 |
Alpine Immune Sciences Inc
(ALPN)
|
S Sale |
162,576
-4.4%
19.963,245,017 USD |
162,576 -4.4% | 19.96 | 3,245,017 USD | |
2023-08-31 | 2023-08-29 |
Silverback Therapeutics Inc
(SBTX)
|
B Purchase |
500,000
+6.6%
6.203,100,000 USD |
500,000 +6.6% | 6.20 | 3,100,000 USD | |
2022-09-16 | 2022-09-16 |
Edgewise Therapeutics Inc
(EWTX)
|
B Purchase |
484,496
+3.6%
10.324,999,999 USD |
484,496 +3.6% | 10.32 | 4,999,999 USD | |
2022-05-20 | 2022-05-18 |
Edgewise Therapeutics Inc
(EWTX)
|
B Purchase |
138,000
+1.0%
7.21994,980 USD |
138,000 +1.0% | 7.21 | 994,980 USD | |
2021-12-23 | 2021-12-21 |
Janux Therapeutics Inc
(JANX)
|
S Sale |
11,100
-4.5%
19.00210,900 USD |
11,100 -4.5% | 19.00 | 210,900 USD | |
2021-12-23 | 2021-12-21 |
Janux Therapeutics Inc
(JANX)
|
S Sale |
108,300
-4.5%
19.002,057,700 USD |
108,300 -4.5% | 19.00 | 2,057,700 USD | |
2021-12-17 | 2021-12-16 |
Janux Therapeutics Inc
(JANX)
|
S Sale |
36,500
-12.9%
19.07696,055 USD |
36,500 -12.9% | 19.07 | 696,055 USD | |
2021-12-17 | 2021-12-16 |
Janux Therapeutics Inc
(JANX)
|
S Sale |
356,800
-12.9%
19.076,804,176 USD |
356,800 -12.9% | 19.07 | 6,804,176 USD | |
2021-06-16 | 2021-06-15 |
Janux Therapeutics Inc
(JANX)
|
B Purchase |
117,650
+71.4%
17.002,000,050 USD |
117,650 +71.4% | 17.00 | 2,000,050 USD | |
2021-06-16 | 2021-06-15 |
Janux Therapeutics Inc
(JANX)
|
B Purchase |
588,203
+27.1%
17.009,999,451 USD |
588,203 +27.1% | 17.00 | 9,999,451 USD | |
2021-02-19 | 2021-02-17 |
Decibel Therapeutics Inc
(DBTX)
|
B Purchase |
555,566
+169.5%
18.0010,000,188 USD |
555,566 +169.5% | 18.00 | 10,000,188 USD | |
2021-02-19 | 2021-02-17 |
Decibel Therapeutics Inc
(DBTX)
|
B Purchase |
1,111,100
+40.7%
18.0019,999,800 USD |
1,111,100 +40.7% | 18.00 | 19,999,800 USD | |
2021-02-19 | 2021-02-17 |
Corvus Pharmaceuticals Inc
(CRVS)
|
B Purchase |
1,285,714
+19.0%
3.504,499,999 USD |
1,285,714 +19.0% | 3.50 | 4,499,999 USD | |
2020-12-30 | 2020-12-28 |
Alpine Immune Sciences Inc
(ALPN)
|
S Sale |
600,000
-16.3%
14.258,550,000 USD |
600,000 -16.3% | 14.25 | 8,550,000 USD | |
2020-12-08 | 2020-12-08 |
Silverback Therapeutics Inc
(SBTX)
|
B Purchase |
952,377
+inf%
21.0019,999,917 USD |
952,377 +inf% | 21.00 | 19,999,917 USD | |
2020-12-08 | 2020-12-08 |
Silverback Therapeutics Inc
(SBTX)
|
B Purchase |
238,100
+88.4%
21.005,000,100 USD |
238,100 +88.4% | 21.00 | 5,000,100 USD | |
2020-09-29 | 2020-09-25 |
PMV Pharmaceuticals Inc
(PMVP)
|
B Purchase |
475,000
+inf%
18.008,550,000 USD |
475,000 +inf% | 18.00 | 8,550,000 USD | |
2020-09-29 | 2020-09-25 |
PMV Pharmaceuticals Inc
(PMVP)
|
B Purchase |
475,000
+inf%
18.008,550,000 USD |
475,000 +inf% | 18.00 | 8,550,000 USD | |
2019-07-01 | 2019-07-01 |
Corvus Pharmaceuticals Inc
(CRVS)
|
B Purchase |
59,243
+0.9%
3.91231,640 USD |
59,243 +0.9% | 3.91 | 231,640 USD | |
2019-07-01 | 2019-06-28 |
Corvus Pharmaceuticals Inc
(CRVS)
|
B Purchase |
565,178
+9.4%
3.722,102,462 USD |
565,178 +9.4% | 3.72 | 2,102,462 USD | |
2019-07-01 | 2019-06-27 |
Corvus Pharmaceuticals Inc
(CRVS)
|
B Purchase |
32,923
+0.6%
3.34109,963 USD |
32,923 +0.6% | 3.34 | 109,963 USD | |
2019-06-26 | 2019-06-24 |
Prevail Therapeutics Inc
(PRVL)
|
B Purchase |
882,352
+6.8%
17.0014,999,984 USD |
882,352 +6.8% | 17.00 | 14,999,984 USD | |
2019-01-23 | 2019-01-18 |
Alpine Immune Sciences Inc
(ALPN)
|
B Purchase |
372,439
+11.3%
5.371,999,997 USD |
372,439 +11.3% | 5.37 | 1,999,997 USD |